These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12034807)

  • 1. First-line therapy with temozolomide induces regression of primary CNS lymphoma.
    Herrlinger U; Küker W; Platten M; Dichgans J; Weller M
    Neurology; 2002 May; 58(10):1573-4. PubMed ID: 12034807
    [No Abstract]   [Full Text] [Related]  

  • 2. A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.
    Wong SF; Gan HK; Cher L
    J Clin Neurosci; 2012 Nov; 19(11):1501-5. PubMed ID: 22995759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up.
    Pulczynski EJ; Simonsen MR; Kuittinen O; Fagerli UM; Erlanson M; Fluge Ø; Leppä S; Østenstad B; Fosså A; Eriksson M; El-Galaly T; Kuitunen H; Papworth K; Ljungqvist M; Pedersen MB; Pollari M
    Haematologica; 2024 Jul; 109(7):2359-2363. PubMed ID: 38546689
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.
    Santisteban M; Nieto Y; De la Cruz S; Aristu J; Zubieta JL; Fernández Hidalgo O
    Clin Transl Oncol; 2007 Jul; 9(7):465-7. PubMed ID: 17652061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide: Expanding its role in brain cancer.
    Mrugala MM; Adair J; Kiem HP
    Drugs Today (Barc); 2010 Nov; 46(11):833-46. PubMed ID: 21225022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
    Meije Y; Lizasoain M; García-Reyne A; Martínez P; Rodríguez V; López-Medrano F; Juan RS; Lalueza A; Aguado JM
    Clin Infect Dis; 2010 Jun; 50(12):e73-6. PubMed ID: 20455691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide in patients with high grade gliomas.
    Brandes AA; Pasetto LM; Vastola F; Monfardini S
    Oncology; 2000 Sep; 59(3):181-6. PubMed ID: 11053983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future directions for temozolomide therapy.
    Yung WK
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
    Enting RH; Demopoulos A; DeAngelis LM; Abrey LE
    Neurology; 2004 Sep; 63(5):901-3. PubMed ID: 15365145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
    Pitini V; Arrigo C; Righi M
    Cancer; 2004 Dec; 101(12):2900-1; author reply 2901-2. PubMed ID: 15529311
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.
    Clark SW; Taylor J; Wang DL; Abramson JS; Batchelor TT
    Neurology; 2013 Jul; 81(1):93-4. PubMed ID: 23685934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
    Omuro A; Chinot O; Taillandier L; Ghesquieres H; Soussain C; Delwail V; Lamy T; Gressin R; Choquet S; Soubeyran P; Huchet A; Benouaich-Amiel A; Lebouvier-Sadot S; Gyan E; Touitou V; Barrié M; del Rio MS; Gonzalez-Aguilar A; Houillier C; Delgadillo D; Lacomblez L; Tanguy ML; Hoang-Xuan K
    Lancet Haematol; 2015 Jun; 2(6):e251-9. PubMed ID: 26688235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide for relapsed primary CNS lymphoma.
    Osmani AH; Masood N
    J Coll Physicians Surg Pak; 2012 Sep; 22(9):594-5. PubMed ID: 22980617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma.
    Yip PL; Lam CP; Lau WP; Luk TH; Lau SJ
    Ann Hematol; 2021 Dec; 100(12):3049-3050. PubMed ID: 32978674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Temozolomide--a new antitumor preparation in the treatment of central nervous system malignant tumors].
    Papuashvili GSh; Gagua RO; Ninua NG
    Georgian Med News; 2006 May; (134):31-4. PubMed ID: 16783060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is protracted low-dose temozolomide feasible in glioma patients?
    Tosoni A; Cavallo G; Ermani M; Scopece L; Franceschi E; Ghimenton C; Gardiman M; Pasetto L; Blatt V; Brandes AA
    Neurology; 2006 Feb; 66(3):427-9. PubMed ID: 16476947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete response to temozolomide treatment in an elderly patient with recurrent primary central nervous system lymphoma--case report.
    Makino K; Nakamura H; Kudo M; Takeshima H; Kuratsu J
    Neurol Med Chir (Tokyo); 2007 May; 47(5):229-32. PubMed ID: 17527051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: a patient with primary CNS lymphoma treated with temozolomide to complete response.
    Lerro KA; Lacy J
    J Neurooncol; 2002 Sep; 59(2):165-8. PubMed ID: 12241110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma.
    Reni M; Ferreri AJ; Landoni C; Villa E
    J Natl Cancer Inst; 2000 Apr; 92(7):575-6. PubMed ID: 10749917
    [No Abstract]   [Full Text] [Related]  

  • 20. Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide.
    Beauchesne P
    J Clin Oncol; 2002 Jul; 20(14):3180-1; author reply 3181. PubMed ID: 12118035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.